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Background: The nucleocapsid domain of Gag and mature nucleocapsid protein (NC) act as nucleic acid chaperones
and facilitate folding of nucleic acids at critical steps of retroviral replication cycle. The basic N-terminus of HIV-1 NC
protein was shown most important for the chaperone activity. The HIV-2 NC (NCp8) and HIV-1 NC (NCp7) proteins
possess two highly conserved zinc fingers, flanked by basic residues. However, the NCp8 N-terminal domain is
significantly shorter and contains less positively charged residues. This study characterizes previously unknown,
nucleic acid chaperone activity of the HIV-2 NC protein.
Results: We have comparatively investigated the in vitro nucleic acid chaperone properties of the HIV-2 and HIV-1 NC
proteins. Using substrates derived from the HIV-1 and HIV-2 genomes, we determined the ability of both proteins to
chaperone nucleic acid aggregation, annealing and strand exchange in duplex structures. Both NC proteins displayed
comparable, high annealing activity of HIV-1 TAR DNA and its complementary nucleic acid. Interesting differences
between the two NC proteins were discovered when longer HIV substrates, particularly those derived from the HIV-2
genome, were used in chaperone assays. In contrast to NCp7, NCp8 weakly facilitates annealing of HIV-2 TAR RNA to its
complementary TAR (−) DNA. NCp8 is also unable to efficiently stimulate tRNALys3 annealing to its respective HIV-2 PBS
motif. Using truncated NCp8 peptide, we demonstrated that despite the fact that the N-terminus of NCp8 differs from
that of NCp7, this domain is essential for NCp8 activity.
Conclusion: Our data demonstrate that the HIV-2 NC protein displays reduced nucleic acid chaperone activity compared
to that of HIV-1 NC. We found that NCp8 activity is limited by substrate length and stability to a greater degree than that
of NCp7. This is especially interesting in light of the fact that the HIV-2 5′UTR is more structured than that of HIV-1. The
reduced chaperone activity observed with NCp8 may influence the efficiency of reverse transcription and other key steps
of the HIV-2 replication cycle.
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HIV infection in humans can be caused by two viruses:
HIV-1 and the less pathogenic HIV-2 [1,2]. HIV-2 is more
closely related to SIVMAC and has only limited genome
and protein sequence identity with HIV-1. However, HIV-
1 and HIV-2 share a similar genome organization, virion
structure and replication cycle. Like other retroviruses
they possess a dimeric genome assembled from two iden-
tical RNA sense strands interacting near their 5′-ends. In* Correspondence: kasiapw@ibch.poznan.pl
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article, unless otherwise stated.the mature viral particles and during early steps of the
replication cycle the genomic RNA is extensively coated
by ~ 2400 copies of the nucleocapsid protein, derived
upon proteolysis of Gag precursor polyproteins [3,4]. This
structural role is only one of a multitude of functions per-
formed by these proteins. The nucleocapsid domain of
Gag and mature nucleocapsid protein (NC) are involved
in critical steps of HIV replication, such as primer tRNA
annealing, reverse transcription, vRNA dimerization and
packaging, virion assembly and proviral integration into
host DNA [5-7]. Many of those functions are correlated
with the ability of NC to act as a nucleic acid chaperone
(NAC). Such chaperone proteins bind nucleic acids withoMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ing misfolded, kinetically trapped structures and enabling
the formation of the thermodynamically most favored
form [6-9]. They do not require ATP and their binding is
no longer required once the most stable nucleic acid
structure is reached [9,10].
The fully processed, mature nucleocapsid proteins of
HIV-1 (NCp7) and HIV-2 (NCp8) are small basic proteins
sharing 67% similarity in amino acid sequence (Figure 1).
They contain two strictly conserved Cys-X2-Cys-X4-His-
X4-Cys (CCHC) zinc finger domains (ZFs) that are linked
by a short basic amino acid sequence (linker region). In
both proteins the ZFs are flanked by a short C-terminus
and basic N-terminal domain. The N-terminal region of
NCp8 is markedly shorter than that of NCp7 and conse-
quently NCp8 is a 48-amino acid protein, whereas NCp7
contains 55 aa [11-13]. Except for the structured ZFs,
retroviral NC proteins are highly flexible in their free
form. However ordering of NCp7 protein structure has
been shown upon binding to nucleic acid, where the disor-
dered N-terminus of the protein forms a 310 helix [14,15].
The N-terminal domain of NCp8 is too short to form
similar helix and limited structural information suggests
that the NA recognition mechanism for NCp8 is different
and the flexible second ZF plays role similar to that of
NCp7 N-terminal region [16,17].
Due to the pleiotropic effect of mutations, testing the
protein NAC activity in cell culture is difficult. Therefore
most studies are based on different experimental in vitro
models, which mimic the steps of retroviral replication,Figure 1 The nucleocapsid protein of HIV-1NL4–3 (NCp7), HIV-2ROD
(NCp8) and the truncated NCp8 mutant ((8–48) NCp8).such as human tRNALys3 annealing to viral RNA or di-
verse strand transfers of reverse transcription. The cellular
tRNALys3 is packaged into nascent virions and serves as a
primer for reverse transcription of HIV RNA [18]. NCp7
chaperones the annealing of an 18 nt fragment at the 3′
end of tRNALys3 to a complementary primer binding site
(PBS) sequence located within the highly structured 5′-
UTR region of the HIV-1 genome [5,19]. The reverse
transcriptase extends the primer tRNALys3, copying the
U5 and R regions and synthesizing the complementary (−)
ssDNA strand. Newly synthesized (−)ssDNA must be
transferred from the 5′ R region (Figure 2) to 3′ R region
of the viral genome to resume elongation; this process is
known as first strand transfer [20]. In the case of HIV-1,
NCp7 chaperones this process and promotes annealing
of (−)ssDNA to the complementary 3′ R sequence [5,21].
NAC activity of HIV-1 nucleocapsid protein (NCp7) has
been extensively studied and numerous efforts have been
undertaken to understand the molecular mechanism of its
activity. In vitro studies have shown nucleic acid aggre-
gation, destabilization, and rapid binding kinetics are
key characteristics of NA chaperones, including NCp7
[9,13,22,23]. It is known that basic amino acids residues
(Arg and Lys) of the N-terminal and linker domain are
involved in sequence nonspecific aggregation and an-
nealing of nucleic acids, whereas NCp7 zinc fingers are
essential for sequence specific binding and duplex NA
destabilization [24-26]. Recent in vitro studies have
demonstrated that NC proteins from several retrovi-
ruses (HIV-1, MuLV, RSV and HTLV-1) display non-
equivalent levels of nucleic acid chaperone activity
[27-29]. In light of this information, it is particularly in-
teresting to compare the NAC activity of nucleocapsid
proteins from HIV-1 and HIV-2.
This study is the first to characterize the in vitro nucleic
acid chaperone activity of the HIV-2 NC protein and to
compare it with HIV-1 NC. Biochemical assays with sub-
strates derived from the HIV-1 and HIV-2 genomes were
performed to compare the ability of both proteins to
chaperone nucleic acid aggregation, annealing and strand
exchange in duplex structures. Using a truncated NCp8
mutant, we found that the short, basic N-terminal domain
is crucial for NCp8 activity. NAC activity of NCp8 and
NCp7 in assays with HIV-1 TAR oligonucleotides was
similar, but when longer HIV-1 substrates or particularly
those derived from the HIV-2 genome were used, interest-
ing differences between these two proteins were discov-
ered. In contrast to NCp7, NCp8 weakly facilitates
annealing of HIV-2 TAR RNA to complementary TAR (−)
DNA. Moreover, NCp8 was unable to efficiently stimulate
tRNALys3 annealing to its respective HIV-2 PBS motif.
Our data suggest that the NAC activity of HIV-1 and
HIV-2 NC proteins is not equivalent and NCp8 exhibits
lower chaperone activity in vitro than NCp7.
Figure 2 Secondary structure models of the HIV-1MAL and HIV-2ROD RNA 5′ R regions.
Figure 3 Comparison of NCp7, NCp8 or (8–48) NCp8 aggregation
activity. Percent TAR1 (−) aggregated by each protein. Assays were
performed as a function of protein concentration as indicated. The
graphs represent averaged data from three independent experiments.
The error bars represent standard deviations.
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The chaperone proteins may act in the sequence inde-
pendent manner; therefore oligonucleotides derived from
HIV-1 genome are usually used in chaperone assays. In
this study we used DNA and RNA oligoncleotides derived
from HIV-1 and HIV-2 genome (Figure 2), marked TAR1,
R1 and TAR2, respectively.
The N-terminal region contributes to the nucleic acid
aggregation activity of NCp8
The ability to cause non-specific aggregation of nucleic
acids is considered one of the principal components of the
NAC activity of retroviral nucleocapsid proteins [11,12,30].
In the case of NCp7, basic residues in the N-terminal do-
main were shown most important for nonspecific inter-
action with and aggregation of nucleic acids and also
annealing activity [12,31]. Interestingly, a major difference
between NCp7 and NCp8 at the amino acid sequence level
is the significantly shorter N-terminal region of NCp8
(Figure 1). Whereas the NCp7 N-terminal segment con-
tains 14 aa residues including 2 Arg and 3 Lys, the corre-
sponding region of NCp8 is composed of 8 aa and 1 Arg
and 2 Lys are present.
Sedimentation assays were used to directly examine NA
aggregation properties of NCp8 and to compare them to
that of NCp7. The TAR1(−) DNA/ and TAR1(+) DNA
were incubated with increasing concentrations of NCp8
or NCp7. Aggregates were pelleted by centrifugation,
whereas free NA and proteins remained in the super-
natant. Both NC proteins effectively aggregated NA at
0.5 μM concentration (protein to nt molar ratio 1:11)
(Figure 3). However, the maximal level of aggregation was
observed upon saturated binding of NA at 1 μM protein
concentration (1 NC per 5.6 nt). Accordingly, despitedifferences in the number of the basic residues and com-
position of their N-terminal domains, NCp7 and NCp8
display very similar nucleic acid aggregation properties.
To directly exploit the role of the NCp8 N-terminal
segment, we performed sedimentation assays with a
truncated NCp8 peptide: (8–48) NCp8, lacking 7 aa resi-
dues from the protein N-terminus (Figure 1). Results
obtained indicated that (8–48) NCp8 displayed reduced
aggregation properties. Only ~ 50% of NA aggregation
was detected at saturating peptide concentration.
Comparison of the nucleic acid annealing activity of NCp8
and NCp7
Proteins considered to be NA chaperones are able to facili-
tate annealing of complementary or nearly complementary
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perimental models were used to assay the in vitro annealing
activity of HIV-1 and HIV-2 NC proteins. The first model
mimics the annealing of the (−)ss DNA strand and acceptor
RNA at the viral 3′ UTR during the first strand transfer of
reverse transcription. The second corresponds to the place-
ment of tRNALys3 on primer binding site (PBS) of HIV-2
RNA. The annealing activity of proteins was measured
using gel mobility shift assays.
TAR and R annealing assays
A comparison of the NCp8 and NCp7 induced annealing
of TAR1(−) and TAR1(+) DNA showed that both proteins
effectively accelerated the formation of DNA duplex.
(Figure 4A). More than 80% of TAR1 DNA oligonucleo-
tides were present in duplex form at saturating NCp8 or
NCp7 concentrations, corresponding to protein to nt
molar ratio 1:6.3 (0.125 μM). This is in agreement with
previous reports showing that saturated levels of protein,
demonstrated to be 1 protein per 5–8 nt, is required for
optimal NCp7 chaperone activity [22,27,30,32]. Moreover,
NCp7 and NCp8 displayed comparable, high annealing
activity of TAR1(−) DNA and TAR1 RNA (Figure 4B).
Interestingly, we observed a difference between NCp7 and
NCp8 in assays utilizing longer HIV-1 R region oligonucle-
otides (Figure 4C). The concentration of NCp7 required forA
C
Figure 4 Comparison of NCp7, NCp8 or (8–48) NCp8 annealing activit
as a function of protein concentration as indicated. Annealing of TAR1(−)D
(C), TAR2(−)DNA/TAR2 RNA (D). The graphs represent averaged data from
The error bars represent standard deviations.effective annealing of R1(−) and R1(+) DNA was lower
than that of NCp8. Almost 90% of R1 strands were
annealed at 0.125 μM NCp7 but only ~ 30% at the same
concentration of NCp8. However at saturating NCp8 or
NCp7 concentrations (0.25 μM, 1NC per 5.3 nt) the
R1(−)/R1(+) annealing was close to 90% for both pro-
teins. The R1 oligonucleotides are longer than TAR1
(96 nt vs. 56 nt) and in addition to the TAR hairpin, a
second short poly(A) hairpin may be forming at the 3′
end. To further compare NCp8 and NCp7 activities we
performed annealing assays with TAR2 oligonucleotides
(123 nt) derived from HIV-2 RNA (Figure 2). The TAR2
RNA forms a more complex structure than TAR-1 RNA
[33,34]. We observed that NCp8 was not able to effectively
anneal TAR2 RNA and TAR2(−) DNA, at a saturating
NCp8 concentration (2.5 μM, 1NC per 6.8 nt) only ~ 25%
annealing was measured (Figure 4D). This is in marked
contrast to the NCp7 reaction, were ~ 90% of TAR2
strands were annealed at the same protein concentration.
tRNALys3/PBS annealing assays
HIV-1 and HIV-2 utilize tRNALys3 as a primer for reverse
transcription and consequently both viruses posses a com-
plementary PBS in their 5′UTRs [35]. The unmodified
tRNALys3 and a 182 nt HIV-2 PBS motif transcript were
used to compare NCp7 and NCp8 induced tRNALys3B
D
y. The assays were performed using different DNA and RNA substrates
NA/TAR1(+)DNA (A), TAR1(−)DNA/TAR1 RNA (B), R1(−)DNA/R1(+)DNA
three independent gel shift annealing experiments for each protein.
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annealing to the HIV-2 PBS motif significantly better than
NCp8 (Figure 5). Whereas ~ 60% annealing was measured
at saturating NCp7 concentration (1.5 μM, 1NC per
4.5 nt), at the same concentration of NCp8 only ~ 30% an-
nealing was detected. Interestingly, in marked contrast to
NCp7, a further increase in NCp8 concentration had only
a minor effect on tRNALys3/HIV-2 PBS motif annealing,
and even at a very high NCp8 concentration (3 μM) only
40% annealing was observed.
Role of the basic N-terminal domain in NCp8 annealing
activity
To further explore the role of the NCp8 N-terminal do-
main, annealing assays with different DNA and RNA sub-
strates were also performed with a truncated version of
NCp8. At a saturating concentration, the (8–48) NCp8 fa-
cilitated annealing of the simplest substrate pair TAR1(−)
to TAR1(+) DNA, but at reduced level (40%) comparing
to NCp8 (Figure 4A). Importantly, we found that (8–48)
NCp8 was completely unable to facilitate annealing of
TAR1(−) DNA/TAR1 RNA, R1(−)/R1(+) DNA and TAR2
RNA/TAR2(−) DNA strands even at peptide concentra-
tion higher than saturation level (Figure 4B,C,D). The
truncated NCp8 also did not promote the annealing of
tRNALys3 to the HIV-2 PBS motif (Figure 5). These data,
together with the sedimentation assay data presented
above, strongly support the contribution of the N-
terminal region in NCp8 chaperone activity.
Strand exchange activity of NCp8 is lower than NCp7
The strand exchange assays represent a more complex ap-
proach to study the chaperone activity of a given protein.
In these assays, the protein’s capacity to destabilize the
structure of DNA or RNA and to enable formation of theFigure 5 Annealing assay using tRNALys3 and the HIV-2 PBS
motif in the presence of increasing concentrations of NCp7,
NCp8 or (8–48) NCp8. The graph represents the averaged percent
of annealed strands from three independent gel shift experiments
for each protein. The error bars represent standard deviations.most stable structure can be examined [22,36]. We used
two types of strand exchange assays. In the first type, we
tested the ability of both proteins to promote the ex-
change of a mismatched DNA strand in an imperfect
DNA duplex by a matched DNA strand. In the second, we
tested protein induced exchange of an RNA strand in an
RNA/DNA heteroduplex by a complementary (+) DNA
strand.
The DNA/DNA strand exchange assays
These assays utilized three DNA oligonucleotides derived
from the HIV-1 R region: R1(+), R1(−) and a mismatched
R1(−)mut containing seven mutations at its 3′ end. We also
performed analogous assays with shorter DNA substrates
corresponding to HIV-1 TAR: TAR1(+), TAR1(−) and
TAR1(−)mut. The DNA strand exchange assays were per-
formed similarly to those previously described [37]. Briefly,
an imperfect duplex was formed by heat annealing (+)
DNA and mismatched (−) DNAmut. Next, the duplex was
incubated with fully complementary, matched (−) DNA in
the presence of NCp8 or NCp7 (Figure 6A).
NCp7 effectively stimulated DNA strand exchange by
replacing the mutated strand for the complementary
strand in the initial, imperfect duplex in both assays,
with short TAR1 (56 nt) and long R1 (96 nt) substrates
(Figure 6B,C,D). We observed that NCp8 also displayed
DNA strand exchange activity in vitro, however it was
lower than NCp7. The difference between NCp7 and
NCp8 was more evident in the assay with R1 substrates,
where unwinding of the longer duplex and annealing of
longer substrates are required for efficient strand ex-
change. 90% strand exchange in the R1(+)/R1(−)mut
DNA duplex was observed at concentrations of NCp7
even below saturating (0.25 μM, corresponding to 1 NC
per 12.7 nt) (Figure 6B,C). In contrast, NCp8 in those
same conditions yielded only about 30% exchange. Even
at a saturating concentration of NCp8 (0.5 μM, 1 NC
per 6.3) exchange level reached only ~ 50%. A further in-
crease in NCp8 concentration of up to 1 μM (1NC per
3.2 nt) led to only minor improvement in the exchange
reaction to 55% (Figure 6B,C) and 2.5 μM concentration
of NCp8 was required for 80% of exchange (Additional
file 1: Figure S1). In the assays with short TAR1 DNA
substrates almost 90% exchange was detected at a satur-
ating NCp7 concentration (0.25 μM, 1NC per 7.4 nt),
but at the same concentration of NCp8, only ~ 60% ex-
change was measured (Figure 6D). However, in this case,
a further increase of NCp8 concentration led to a signifi-
cant activation of the exchange reaction.
The RNA/DNA strand exchange assays
Further assays aimed to determine the ability of HIV-2
nucleocapsid protein to stimulate RNA strand exchange
in a preformed RNA/DNA duplex (Figure 7A). These
A B
C D
Figure 6 Comparison of NCp7 and NCp8 DNA strand exchange activity. (A) Schematic of the DNA/DNA strand exchange reaction. (B) A
representative electrophoretic analysis of DNA strand exchange in the R1(+)DNA/R1(−) DNAmut duplex at increasing concentrations of NCp7 or
NCp8. Lane 1: R1(+) DNA only; lane 2: heat-annealed R1(+) DNA/R1(−)DNA; lane 3: heat-annealed R1(+) DNA/R1(−) DNAmut; lane 4: the heat-annealed
R1(+)DNA/R1(−) DNAmut duplex incubated with R1(−) DNA; lanes 5 – 9: strand exchange reaction at 0.06, 0.125, 0.25, 0.5 and 1 μM NCp7; lanes
10 – 14: strand exchange reaction at 0.06, 0.125, 0.25, 0.5 and 1 μM NCp8. (C) Percentage of R1(−) DNAmut exchanged, measured as a ratio of perfect
to imperfect duplex. (D) Percentage of TAR1(−) DNAmut exchanged, measured as a ratio of perfect to imperfect duplex. The graphs represent the
averaged data from three independent experiments. The error bars represent standard deviations.
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DNA exchange assays with R1 and TAR1 substrates de-
scribed above, but TAR1 RNA (56 nt) was used instead of
mismatched (−) DNA strands. We found that NCp8 pro-
moted RNA strand exchange less effectively than NCp7
and the difference in the proteins’ activity was more evi-
dent in the assays with the longer R1 substrates than with
TAR1 oligonucleotides. In these two assays, the initial
RNA/DNA heteroduplexes are the same length (the polyA
sequence is not involved in duplex formation), but the
length of final duplexes differ: TAR1(−)/TAR1(−) is 56 bp,
while R1(−)/R1(+) is 96 bp. The exchange level of TAR1
RNA for R1(+) in the initial R1(−) DNA/TAR1 RNA du-
plex was ~ 95% at 0.25 μM NCp7 (1NC per 11 nt),
whereas only ~ 60% was observed for NCp8 (Figure 7B,
C). NCp8, even at levels above saturation (1 μM; 1NC per
2.75 nt), did not stimulate RNA strand exchange in the
R1(−) DNA/TAR1 RNA. However, in the assay withshorter oligonucleotides (Figure 7D), NCp8 significantly
increased exchange of TAR1 RNA for TAR1(+) DNA in
the TAR1(−) DNA/TAR1 RNA heteroduplex at a saturat-
ing concentration (0.125 μM). As a result of protein medi-
ated strand exchange, a thermodynamically less stable
DNA/DNA duplex was formed. An RNA/DNA heterodu-
plex is more stable than the analogous DNA/DNA duplex.
The calculated Tm for TAR1(−) DNA/TAR1 RNA is
84.8°C, whereas it is 75.5°C for the TAR1(−) DNA/TAR(+)
DNA duplex [38]. However, a minimum free energy state
of the entire system differs.
Discussion and conclusions
In this work, the nucleic acid chaperone activity of two
nucleocapsid proteins, HIV-1 (NCp7) and HIV-2 (NCp8),
were compared in vitro. The activity of NCp7 has been ex-
tensively studied, however diversity in the approaches and
conditions used prompted us to simultaneously assay both
A B
C D
Figure 7 Comparison of NCp7 and NCp8 RNA strand exchange activity. (A) A schematic of the RNA/DNA strand exchange reaction. Note
that the TAR1 RNA may adopt a stem-loop structure, not shown here. (B) A representative electrophoretic analysis of RNA strand exchange in the
R1(−) DNA/TAR1 RNA duplex at increasing concentrations of NCp7 or NCp8. Lane 1: R1(−) DNA only; lane 2: heat-annealed R1(−) DNA/TAR1 RNA;
lane 3: heat-annealed R1(−)DNA/R1(+)DNA; lane 4: heat-annealed R1(−) DNA/TAR1 RNA incubated with R1(+)DNA at 37°C; lanes 5 – 9: strand
exchange reaction at 0.06, 0.125, 0.25, 0.5 and 1 μM NCp7; lanes 10 – 14: strand exchange reaction at 0.06, 0.125, 0.25, 0.5 and 1 μM NCp8.
(C) Percentage of TAR1 RNA exchanged, measured as a ratio of R1(−) DNA/R1(+)DNA to R1(−) DNA/TAR1 RNA duplex. (D) Percentage of TAR1
RNA exchanged, measured as a ratio of TAR1(−) DNA/TAR1(+) DNA to TAR1(−) DNA/TAR1 RNA duplex. The graphs represent averaged data from
three independent experiments. The error bars represent standard deviations.
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compare the aggregation, annealing and strand exchange
activities of these two related NC proteins.
Sequence non-specific aggregation of NA leading to an
increase in local concentration is considered a major
mechanism of NC-induced NA annealing [11,23,30]. An
electrostatic model of NCp7-induced NA aggregation has
been proposed and the highly cationic N-terminal domain
of NCp7 is thought to be crucial for both NA aggregation
and annealing activity [11,12,30]. The truncated NCp7
peptide (12–55) NCp7 or the NCp7 cationic N-terminal
pentamutant (with all 5 basic residues in the N-terminal
region replaced with alanines) did not cause nucleic acid
aggregation or chaperone the annealing of HIV-1 TAR(−)
DNA/TAR RNA at saturating protein concentrations
[12,31]. Moreover, mutation of three of five basic residuesin the N-terminus strongly impaired NCp7 activity [31].
Despite the fact that the N-terminal domain of NCp8 is
shorter and contains only three positively charged amino
acid residues, both NCp7 and NCp8 display similar NA
aggregation activities and TAR1(−) DNA/TAR1 RNA
annealing levels (Figures 3 and 4B). Basic residues distrib-
uted in other NCp8 regions, such as the linker and ZFs,
may also participate in protein activity. Since the N-
terminal segment of NCp8 is shorter and the flexibility of
the basic linker region is limited, it has been proposed that
the hydrophobic cleft in the second ZF of NCp8 plays a
role similar to that of the N-terminal region of NCp7 in
nonspecific NA recognition [16,17]. Although we cannot
exclude these regions, our results obtained with the
(8–48) NCp8 peptide, which displays reduced aggregation
activity (Figure 3) and was unable to facilitate annealing of
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port the crucial role of basic N-terminal segment in NCp8
chaperone activity.
The chaperone activity of retroviral nucleocapsid pro-
teins plays an important role in facilitating remodelling of
nucleic acid strands during reverse transcription [39]. We
performed several gel shift assays to examine the ability of
both proteins to chaperone nucleic acids annealing and
strand exchange in duplex nucleic acid structures. Anneal-
ing of HIV-1 TAR(−) DNA to a complementary TAR
RNA or TAR(+) DNA is often use as model assay to study
the NA chaperone activity of proteins. Spontaneous for-
mation of the TAR1(−) DNA/TAR1 RNA duplex in vitro
is extremely slow at physiological conditions, however
addition of NCp7 accelerates the annealing rate about
3000-fold [22,32]. The mechanism of HIV-1 TAR hairpins
annealing has been extensively studied and it was deter-
mined that NCp7 switches the inefficient loop – loop
pathway to the zipper pathway, leading to an efficient an-
nealing reaction [40-42]. Although TAR is considered of
major importance in first strand transfer, the transferred (−)
ssDNA consists of the entire R (TAR, polyA) and U5 se-
quence. Moreover, in the 3′ R region, in addition to TAR, a
shortened polyA hairpin is present and stabilization of the
polyA hairpin in the 5′ and 3′ R regions inhibited strand
transfer in HIV-1 [20]. We found that NCp8 and NCp7 fa-
cilitate TAR1(−) DNA/TAR1(+) DNA and TAR1(−) DNA/
TAR1 RNA annealing with high, comparable efficiencies
(Figure 4A,B). However, NCp8 is less efficient in the an-
nealing of longer substrates corresponding to the entire
HIV-1 R region (Figure 4C). These data suggest that the
additional sequence, which is able to form a shortened
polyA hairpin, inhibits NCp8-induced annealing.
In view of this observation, it was interesting to test the
ability of NCp8 to facilitate annealing of its cognate TAR2
hairpins. Present at the 5′ end of the HIV-2 genome,
TAR2 (Figure 2) is more complex and may exist in two
highly structured forms: a three-hairpin branched form
[34] and an extended form with two hairpins [33]. Struc-
tural in silico analysis of the HIV-2 RNA 3′end R region
[43], supported by a recently published structure of the
closely related SIVMAC genome [44], indicates that the 3′
TAR2 RNA may adopt the stable three-hairpin form. In
contrast to NCp7, NCp8 facilitates the in vitro annealing
of TAR2 RNA/TAR2(−) DNA only very weakly at saturat-
ing concentrations (Figure 4D). Numerous studies have
been dedicated to explaining the relationship between nu-
cleic acid structure and NC mediated first strand transfer.
The structure and the degree of thermostability of nucleic
acid substrates are proposed to be major factors influen-
cing NC-chaperoned first strand transfer [36,39,45]. NCp7
displays only a weak destabilization activity, which
strongly depends on the stability of the NA. Additionally,
the local structure of the (−)ssDNA (bulges, internalloops) and the stability of the acceptor RNA are both crit-
ical [20,24,46,47]. Results from annealing assays per-
formed with diverse RNA and DNA oligonucleotides
suggest that NCp8 chaperone activity is limited by the sta-
bility and length of the substrates to a greater degree than
that of NCp7.
Important confirmation of this observation was ob-
tained in the strand exchange assays (Figures 6 and 7).
Strand exchange activity is the result of the combined ac-
tion of both helix destabilization and annealing activities
[9,22,48]. The DNA and RNA strand exchange assays with
shorter substrates demonstrate that NCp8 displays DNA
and RNA strand exchange activity, but that a higher con-
centration relative to that of NCp7 is required for effective
exchange (Figure 7C,D). With longer or more stable sub-
strates, a significant decrease in exchange efficiency was
observed in the presence of NCp8, but not NCp7. The
weaker activity of NCp8 in the DNA and RNA exchange
assays with the R1 substrates, compared to that with the
shorter TAR1 substrates, may be the result of lower helix
destabilization and/or lower annealing activity. More ad-
vanced biophysical studies are needed to determine the
details of NCp8 mediated destabilization.
It is generally accepted that the mechanism of strand
exchange depends on chaperone protein induced desta
bilization of a nucleic acid duplex and formation of a more
thermodynamically stable duplex with another nucleic
acid strand where complementarities are more extended
[9,22,48]. Although this statement applies to our DNA
strand exchange assays, the ability of both NCp7 and
NCp8 to promote the exchange of TAR1 RNA for
TAR1(+) DNA in the initial heteroduplex may seem
surprising, as the final duplex is a thermodynamically
less stable form. However, chaperone proteins always
drive the entire system to a minimum free energy state
[49] and the TAR1 RNA released during this strand
exchange may form a very stable hairpin (ΔG = −
25.7 kcal/mol). Free energy calculation shows that the
overall free energy of the final products is indeed lower
(TAR1 RNA ΔG = −25.7 kcal/mol and TAR1(−) DNA/
TAR1(+) DNA ΔG = − 62.06 kcal/mol) than that of the
reactant system (TAR1(+) DNA ΔG = −10.04 kcal/mol
and TAR(−) DNA/TAR1 RNA ΔG = − 69.6 kcal/mol).
Thus, the exchange effect observed arises from the cap-
acity of NC to lower the overall system free energy and
thereby release the TAR1 RNA from the DNA/RNA
hybrid.
A prominent annealing reaction in the HIV replica-
tion cycle is the placement of tRNALys3 onto the primer
binding site sequence (PBS) located in the 5′ UTR of
the viral RNA. It is not definitively established whether
it is the NC domain of Gag or the mature NC protein
that is crucial for this process in infected cells or vi-
rions. Recent studies show that the initial tRNALys3
Pachulska-Wieczorek et al. Retrovirology 2014, 11:54 Page 9 of 13
http://www.retrovirology.com/content/11/1/54annealing is probably promoted by Gag, whereas the
final tRNALys3/vRNA remodeling step is facilitated by
the mature NC [5,50,51]. Numerous studies have dem-
onstrated that in vitro, NCp7 chaperones tRNALys3 an-
nealing onto the HIV-1 PBS motif very efficiently.
Interestingly, we found that NCp8 very inefficiently fa-
cilitated in vitro annealing of tRNALys3 to its cognate
PBS motif (Figure 5). Additional interactions between
tRNALys3 and HIV-1 RNA outside the PBS have been
identified as crucial for viral replication [52] and other
factors, such as cellular RNA helicase A [53], lysyl-
tRNA synthetase [54] or viral Vif protein [55] may play
a role in tRNALys3 placement. The tRNALys3/HIV-2
RNA complex has not been investigated as extensively as
that of HIV-1, however structural studies of the heat-
annealed complex supported by mutational analysis
showed interactions occurring in other secondary struc-
ture elements outside of the acceptor stem of tRNALys3
and the PBS [56,57]. Since the HIV-2 PBS motif has a
more complex structure and NCp8 appears to be weaker
chaperone, additional factors may be even more important
for tRNALys3/HIV-2 PBS annealing than for HIV-1.
In conclusion, our in vitro data suggest that the HIV-2
NC protein displays reduced nucleic acid chaperone activ-
ity compared to that of HIV-1 NC. We found that NCp8
activity is limited by substrate length and stability to a
greater degree than that of NCp7. This is especially inter-
esting in light of the fact that the HIV-2 5′UTR structure
is more complicated than that of HIV-1 [33,34,58]. Our
assays with substrates derived from the HIV-2 genome
showed important differences between NCp8 and NCp7.
Our data indicate that to better understand the biological
relevance of chaperone proteins from different retrovi-
ruses, studies using cognate RNA and DNA fragments
should be considered. The lower chaperone activity ob-
served with NCp8 may influence the efficiency of reverse
transcription and other key steps of the HIV-2 replication
cycle. Additionally, other viral or cellular proteins may be
engaged in chaperoning these processes in HIV-2. As cru-
cial factors in retroviral replication, NC proteins are often
proposed as being promising targets for antiretroviral
therapy [59,60], therefore it is important that their proper-
ties are studied extensively. We believe that the above
results will contribute to understanding the differences
between retroviral nucleocapsid proteins and in the long
term, between HIV-2 and the more pathogenic HIV-1.
Methods
Proteins
NCp7 and NCp8 proteins were purified as recombinant
glutathione S-transferase (GST) fusion proteins from E.
coli BL21—Codon Plus (DE3)—RIL cells (Stratagene),
based on engineered expression vectors pGEX-4 T-3-
NCp7 and pGEX-4 T-3-NCp8 [58]. The HIV-1NL4–3 andHIV-2ROD nucleocapsid protein coding sequencescoli
BL21—Codon Plus (DE3)—RIL cells (Stratagene), based
on engineered expression vectors pGEX-4 T-3-NCp7 and
pGEX-4 T-3-NCp8 [58]. The nucleocapsid protein coding
sequences of HIV-1NL4–3 and HIV-2ROD were taken from
http://ncbi.nlm.nih.gov. GST-tagged proteins were puri-
fied by affinity chromatography on Glutathione-Sepharose
(Amersham Pharmacia Biotech.) and the GST tag was
cleaved off with thrombin enzyme. The proteins were
further purified on a Superdex 200 FPLC column, and
molecular masses were determined using MALDI TOF
(Autoflex, Bruker Daltonics). The purified proteins were
lyophilized and stored at −80°C. Synthetic (8–48) NCp8
peptide was obtained from ThermoFischer Scientific.
Proteins were dissolved in freshly prepared, oxygen-free
buffer containing 30 mM HEPES pH 6.5, 30 mM NaCl
and 0.1 mM ZnCl2. Activity of each protein preparation
was compared with the activity of the synthetic full-length
(48aa) NCp8 (Additional file 2: Figure S2).DNA and RNA substrates
ODNs corresponding to the TAR and the R sequences of
HIV-1MAL or HIV-2ROD were purchased from Genomed
(Poland). Oligonucleotide sequences are presented in
Table 1. TAR1(−)mut DNA and R1(−)mut DNA correspond
to HIV-1 antisense TAR or R, but each contain 7 mis-
matches at the 3′ end (Table 1, residues shown in italic).
R1(−)mut DNA was designed based on [37]. RNA oligonu-
cleotides were synthesized with the Ambion T7-MEGA
shortscript following the manufacturer’s protocol, based on
PCR generated templates. Transcripts were purified by de-
naturing gel electrophoresis (8 M urea) in 1× TBE, followed
by elution and ethanol precipitation. Purified RNA was dis-
solved in sterile water and stored at −20°C. TAR and R
ODNs were 32P-labelled at the 5′-end with [γ-32P]ATP
using T4 polynucleotide kinase (Fermentas) according to
manufacturer’s protocol and were purified using NucAway
Spin Columns (Life Technologies). The in vitro synthesized,
unmodified human tRNALys3 (hereafter referred as
tRNALys3) was 3′-end labelled using [α-32P] pCp and T4
RNA ligase, based on standard protocol.TAR and R oligonucleotides annealing assays
Refolded 32P-labelled antisense DNA oligonucleotide
(1 nM) and complementary, unlabelled sense DNA or
RNA (6 nM) were incubated with increasing protein con-
centrations (0 – 0.5 μM) in buffer A (20 mM Tris–HCl,
pH 7.2, 30 mM NaCl, 0.1 mM MgCl2, 10 μM ZnCl2 and
5 mM DTT) at 37°C for 5 minutes. Subsequently, the re-
actions (10 μl) were chilled on ice and quenched with 5 μl
of Stop Solution (20% glycerol, 20 mM EDTA pH 8.0,
0.2% SDS, 0.25% bromophenol blue and 0.4 mg/ml yeast
tRNA), to denature proteins and induce their release from
Table 1 The sequences of TAR and R oligonucleotides used in this study
Name Sequence 5′ ‐ 3′‐ Length
TAR1(+) DNA GGTCTCTCTTGTTAGACCAGGTCGAGCCCGGGAGCTCTCTGGCTAGCAAGGAACCC 56
TAR1(−) DNA GGGTTCCTTGCTAGCCAGAGAGCTCCCGGGCTCGACCTGGTCTAACAAGAGAGACC 56
TAR1(−)mut DNA GGGTTCCTTGCTAGCCAGAGAGCTCCCGGGCTCGACCTGGTCTTTGAACTCAGAGG 56
TAR1 RNA GGUCUCUCUUGUUAGACCAGGUCGAGCCCGGGAGCUCUCUGGCUAGCAAGGAACCC 56
R1(+) DNA GGTCTCTCTTGTTAGACCAGGTCGAGCCCGGGAGCTCTCTGGCTAGCAAGGAACCCACTGCTTAAGCCTCAATAAAGCTTGCCTTGAGTGCCTCCC 96
R1(−) DNA GGGAGGCACTCAAGGCAAGCTTTATTGAGGCTTAAGCAGTGGGTTCCTTGCTAGCCAGAGAGCTCCCGGGCTCGACCTGGTCTAACAAGAGAGACC 96
R1(−)mut DNA GGGAGGCACTCAAGGCAAGCTTTATTGAGGCTTAAGCAGTGGGTTCCTTGCTAGCCAGAGAGCTCCCGGGCTCGACCTGGTCTAACATCAGTCTCTA 97
TAR2 RNA GGTCGCTCTGCGGAGAGGCTGGCAGATTGAGCCCTGGGAGGTTCTCTCCAGCACTAGCAGGTAGAGCCTGGGTGTTCCCTGCTAGACTCTCACCAGCACTTGGCCGGTGCTGGGCAGACGGCC 123
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PAGE (8%) in 0.5× TBE at 4°C (DNApointer, Biovectis).
tRNALys3/PBS annealing assays
Prior to the annealing reaction, the 32P-labelled tRNALys3
was refolded in 50 mM Hepes (pH 7.5) by heating at 85°C
for 2 minutes and slow cooling to 60°C, followed by
addition of MgCl2 to 10 mM and placement on ice.
The +197 – 379 HIV-2 transcript (hereafter referred to
as HIV-2 PBS motif ) was refolded in 50 mM Hepes,
pH 7.5 by heating at 85°C for 2 minutes and slow cool-
ing to 60°C, followed by addition of MgCl2 to 10 mM.
Subsequently RNA was incubated at 37°C for 10 mi-
nutes and placed on ice. Refolded tRNALys3 was com-
bined with refolded +197 – 379 HIV-2 RNA in a
solution containing 50 mM Hepes, pH 7.5, 20 mM
NaCl, 5 mM DTT, and 1 mM MgCl2. Initially, 10 nM
tRNALys3 was combined with 25 nM HIV-2 PBS motif
and incubated at 37°C for 10 minutes. Upon addition of
protein, the annealing reaction proceeded at 24°C for
30 minutes. Aliquots from the annealing reaction were
quenched by incubation with 1% (w/v) SDS at room
temperature for 10 minutes. The samples were phenol/
chloroform-extracted twice, mixed with loading dye
and separated on an SDS-10% polyacrylamide gel in
1 × TBE at room temperature.
DNA/DNA strand exchange assays
32P-labelled R1(+), R1(−) and R1(−)mut ODNs were separ-
ately heat denatured for 5 minutes at 95°C in water and
chilled on ice. All components were kept at 4°C. Subse-
quently, 1 nM 32P-labelled R1(+) and 5 nM R1(−)mut were
mixed with buffer A to a final concentration of 20 mM
Tris–HCl, pH 7.2, 30 mM NaCl, 0.1 mM MgCl2, 10 μM
ZnCl2 and 5 mM DTT. Reactions were incubated for
30 minutes at 65°C to form the R1(+)/R1(−)mut duplex
and chilled on ice. Subsequently 5 nM R1(−) and varying
concentrations of protein (0–1 μM) were added. Samples
were incubated for 10 minutes at 37°C, chilled on ice and
quenched with 5 μl of Stop Solution. Samples were ana-
lyzed by 8% native PAGE in 0.5× TBE at 4°C. A DNA/
DNA strand exchange assay with 32P-labelled TAR1(+),
TAR1(−) and TAR1(−)mut was performed similar to that
described above.
RNA/DNA strand exchange assays
32P-labelled R1(−), R1(+) and TAR1 RNA oligonucleotides
were separately heat denatured for 5 minutes at 95°C in
water and chilled on ice. All components were kept at 4°C.
Subsequently, 1 nM 32P-labelled R1(−) and 5 nM TAR1
RNA, were mixed with reaction buffer A to a final concen-
tration of 20 mM Tris–HCl, pH 7.2, 30 mM NaCl, 0.1 mM
MgCl2, 10 μM ZnCl2 and 5 mM DTT. Reactions were in-
cubated for 30 minutes at 65°C to form the R1(−)/TAR1RNA duplex and chilled on ice. Subsequently, 5 nM R1(+)
and varying concentrations of protein (0–1 μM) were
added. Samples were incubated for 10 minutes at 37°C,
chilled on ice and quenched with 5 μl of Stop Solution.
An RNA/DNA strand exchange assay with 32P-labelled
TAR1(−), TAR1 RNA and TAR1(+) was performed similar
to that described above. Calculations of the hybridization
thermodynamics were made using HyTher server [38].Sedimentation assays
10 nM 32P-labelled TAR1(−) was combined with 40 nM
complementary unlabelled TAR1(+) in a buffer containing
50 mM HEPES pH 7.5, 20 mM NaCl, and 0.2 mM MgCl2.
Diverse amounts of NCp8 were added (0–2 μM) and reac-
tions (10 μl) were incubated at 37°C for 30 minutes. Sub-
sequently, the mixtures were centrifuged at 11400 rpm for
20 minutes. Supernatants (2 μl) were collected and sub-
jected to scintillation counting.
All gels were autoradiographed and quantitatively ana-
lyzed by phosphorimaging using FLA-5100 phosphorima-
ger with MultiGaugeV 3.0 software (FujiFilm).
In all cases, at least three independent experiments were
performed, and the data presented are representative of
the whole.Additional files
Additional file 1: The NCp8 DNA strand exchange activity. (A) A
representative electrophoretic analysis of DNA strand exchange in the
R1(+) DNA/R1(-) DNAmut duplex at increasing concentrations of NCp8.
Lane 1: R(+) DNA only; lane 2: heat-annealed R1(+) DNA/R1(-) DNA; lane
3: heat-annealed R1(+) DNA/R1(-) DNAmut; lane 4 – 9: strand exchange
reaction at 0.5, 1, 1.5, 2, 2.5, 3 μM NCp8. (B) Percentage of R1(-) mut
exchanged, measured as a ratio of perfect to imperfect duplex. Assays
were performed as described in Methods section. The graph represents
the averaged data from three independent experiments. The error bars
represent standard deviations.
Additional file 2: Comparison of the annealing (left) and strand
exchange (right) activities of recombinant NCp8 proteins from three
independent preparations (NCp8 1, NCp8 2, NCp8 3) and chemically
synthesized NCp8 (NCp8chem). The annealing assays were performed
with TAR1(-) DNA and TAR1(+) DNA substrates. The DNA strand
exchange activity was tested in the assays with R1(+) DNA, R1(-)
DNAmut and R1(-) DNA substrates. Assays were performed as
described in Methods section. The graphs represent the averaged data
from three independent experiments. The error bars represent
standard deviations.Abbreviations
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